Korean J Women Health Nurs.  2018 Dec;24(4):333-335. 10.4069/kjwhn.2018.24.4.333.

Considering Sex and Gender Sensitive Methods in Biomedical and Health Research

• Lee KO

• KMID: 2429684
• DOI: http://doi.org/10.4069/kjwhn.2018.24.4.333

Abstract

No abstract available.

MeSH Terms

Methods*

Reference

1. Wizemann TM, Pardue ML. Exploring the biological contributions to human health: Does sex matter? Board on health sciences policy. Wasington, DC: The National Academies Press;2001. p. 267.

2. Lee HS, Lee SK, Kim YM, Yoe YJ, Pak HY. Guideline for considering sex and gender variables in biomedical research. Center for gendered innovations in science technology research [Internet]. Seoul: KOFWST;2018. cited 2018 September 16. Available from: https://www.kofwst.org/kr/reference/ebook.php?bbs_data=aWR4PTc5MjEmc3RhcnRQYWdlPTAmbGlzdE5vPTI0JnRhYmxlPWNzX2Jic19kYXRhJmNvZGU9ZWJvb2smc2VhcmNoX2l0ZW09JnNlYXJjaF9vcmRlcj0=||&bgu=view&idx=7921&pageNum=&cate.

3. You B, Zhu B, Su X, Liu F, Wang B. Gender differences among elderly patients with primary percutaneous coronary intervention. Aging and Disease. 2018; 9(5):852–860. DOI: 10.14336/AD.2017.1129.

4. Pelletier R, Ditto B, Pilote L. A composite measure of gender and its association with risk factors in patients with premature acute coronary syndrome. Psychosomatic Medicine. 2015; 77(5):517–526. DOI: 10.1097/PSY.0000000000000186.

5. Billimek J, Malik S, Sorkin DH, Schmalbach P, Ngo-Metzger Q, Greenfield S, et al. Understanding disparities in lipid management among patients with type 2 diabetes: gender differences in medication nonadherence following treatment intensification. Womens Health Issues. 2015; 25(1):6–12. DOI: 10.1016/j.whi.2014.09.004.

6. AbuRuz ME, Al-Dweik G. Depressive symptoms and complications early after acute myocardial infarction: gender differences. The Open Nursing Journal. 2018; 12:205–214. DOI: 10.2174/1874434601812010205.

7. DeMeo DL, Ramagopalan S, Kavati A, Vegesna A, Han MK, Yadao A, et al. Women manifest more severe COPD symptoms across the life course. International Journal of Chronic Obstructive Pulmonary Disease. 2018; 13:3021–3029. DOI: 10.2147/COPD.S160270.

8. Mastroianni AC, Faden R, Federman D. Women and health research: ethical and legal issues of including women in clinical studies. Washington, DC: National Academies Press (US);1999. p. 247.

9. Fish EN. The X-files in immunity: sex-based differences predispose immune responses. Nature Reviews Immunology. 2008; 8(9):737–744. DOI: 10.1038/nri2394.

10. Simon V. Wanted: women in clinical trials. Science. 2005; 308(5728):1517. DOI: 10.1126/science.1115616.

11. Yu Y, Chen J, Li D, Wang L, Wang W, Liu H. Systematic analysis of adverse event reports for sex differences in adverse drug events. Scientific Reports. 2016; 6:24955. DOI: 10.1038/srep24955.

12. Collins FS, Tabak LA. Policy: NIH plans to enhance reproducibility. Nature. 2014; 505(7485):612–613.

13. National Institutes of Health. Consideration of sex as a biological variable in NIH-funded research [Internet]. Bethesda, DC: National Institutes of Health;2015. cited 2018 August 13. Available from: https://grants.nih.gov/grants/guide/notice-files/not-od-15-102.html.